This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5,383 
1 out of 1,853 
Years Active: 2022
Title: Ludivine Perrocheau: Innovator in Neurodegenerative Disorder Treatments
Introduction
Ludivine Perrocheau is a prominent inventor based in Paris, France. She has made significant contributions to the field of neurodegenerative disorders through her innovative research and development of pharmaceutical compositions.
Latest Patents
Ludivine holds 1 patent for her invention titled "Method and pharmaceutical composition for use in the treatment of neurodegenerative disorders." This invention focuses on compounds that activate the BASIGIN signaling pathway, specifically agonists of BASIGIN, aimed at treating neurodegenerative disorders.
Career Highlights
Throughout her career, Ludivine has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. Her work in these organizations has been pivotal in advancing research in her field.
Collaborations
Ludivine has collaborated with notable professionals, including Alain Van Dorsselaer and Jose-Alain Sahel, enhancing her research through shared expertise and knowledge.
Conclusion
Ludivine Perrocheau's contributions to the treatment of neurodegenerative disorders highlight her role as an innovative inventor in the pharmaceutical field. Her work continues to inspire advancements in medical research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile